Home > Ampersand Capital Partners acquires Brammer Bio, LLC
Transaction · Life Science

Ampersand Capital Partners acquires Brammer Bio, LLC

Ampersand Capital Partners acquired Brammer Bio, LLC, a life science company in Massachusetts, United States.

Deal at a glance

TargetBrammer Bio, LLC Buyer Ampersand Capital Partners SectorLife Science LocationMassachusetts, United States ValueNot disclosed

Target company

Brammer Bio, LLC
Massachusetts, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Private equity firm · 76 deals on record
76deals, all time
32in this sector
2022latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Syft Technologies Ltd.Same lead buyer · Apr 2022
BioEcho Life Sciences GmbHSame lead buyer · Mar 2022
Ollin Biosciences, Inc.Same sector and country · Nov 2026
OmnioseSame sector and country · Nov 2026
Mithril MedicineSame sector and country · Oct 2026

Questions about this deal

Who acquired Brammer Bio, LLC?Ampersand Capital Partners acquired Brammer Bio, LLC.

What type of deal was it?It was a transaction in the life science sector.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).